Cross-reaction of Sera from COVID-19 Patients with SARS-CoV Assays
Wei Yee Wan, Siew Hoon Lim, Eng Hong Seng
Abstract
SARS-CoV-2 is a new zoonotic coronavirus (CoV) that emerged in Wuhan, China, which was first reported to the World Health Organization (WHO) on 31 December 2019. This coronavirus disease (COVID-19) causes mild to moderate respiratory illness in the majority of patients, but can cause serious complications in the elderly and in those with comorbidities. Poorer resourced countries may not have the capability to equip themselves with complex molecular diagnostic setups. Thus, alternative diagnostic methods maybe crucial to contain outbreaks.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyBetacoronavirusCross reactionsSars virusCoronavirus InfectionsImmunologyAntibodyOutbreakPathologyInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologySARS-CoV-2 detection and testing